Feature
Gastrointestinal medicine Zhenglu Pill has been a regular household medicine used by every household (over 5 years old) since a hundred years ago. Japanese Pharmacopoeia creosote is a natural ingredient that exerts its effect by adjusting the balance of water in the intestines without stopping the movement of the intestines. It is especially effective for gastrointestinal discomfort caused by food or drinking water, soft stools and diarrhea caused by indigestion, as well as soft stools and diarrhea caused by mental stress and colds. The main ingredient of this medicine is creosote of the Japanese Pharmacopoeia, and it is composed of crude drugs such as Axian powder, Cork powder, Licorice powder, and dried tangerine peel powder. It is a slightly moist pill with a specific smell.
Effect
Soft stools, diarrhea, diarrhea caused by food or water, vomiting and diarrhea, diarrhea, diarrhea caused by indigestion, tooth decay pain
Brand
Taiko Pharmaceuticals is mainly engaged in the manufacture of daily pharmaceutical products such as "Zhenglu Pill" and "Zhenglu Pill Sugar Coated A", as well as sales to Japan and overseas.
The sales method in the domestic area of Japan is to provide general consumers through pharmacies. "Shoromaru" has a long history of more than 100 years and has a high brand recognition rate in Japan. "Zhenglu Pill" and "Zhenglu Pill Sugar Coated A" have good curative effect on soft stools, diarrhea, diarrhea caused by food or drinking water, vomiting and diarrhea. In 2017, on the basis of these two products, after nearly 50 years, Dako Pharmaceutical launched a new soft capsule product "Zhenglu Pill QuickC". While carefully maintaining the brand established so far, it also strives to develop and acquire new consumer groups. In addition, the sales products also include the antidiarrheal drug "Pishut antidiarrheal OD tablet (applicable to the self-treatment tax system)" which can be taken without water, and the quasi-drug "Speaker Intestinal Regulator BF".
In terms of overseas sales, it mainly sells to retail stores through agents through its subsidiary Taiko Pharmaceutical (Asia Pacific) Co., Ltd. <Hong Kong>.
In China, it sells in the South China market with Hong Kong as the center, and is developing sales channels in East China, North China, Northeast China and other regions. In addition, export sales are also carried out to the United States, Canada, Thailand, Vietnam, Malaysia, Mongolia and other countries.